| pubmed-article:1330342 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1330342 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:1330342 | lifeskim:mentions | umls-concept:C1257913 | lld:lifeskim |
| pubmed-article:1330342 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:1330342 | lifeskim:mentions | umls-concept:C0334094 | lld:lifeskim |
| pubmed-article:1330342 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:1330342 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:1330342 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:1330342 | pubmed:dateCreated | 1992-11-27 | lld:pubmed |
| pubmed-article:1330342 | pubmed:abstractText | The proliferative activity of tumor cells differing in DNA content (ploidy) and nuclearity was investigated in primary hepatocellular carcinomas of the rat by flow cytometric analysis of collagenase-isolated cells immunostained after labelling with bromodeoxyuridine (BrdU) in vivo. The diploid cell fraction in these euploid tumours was higher than in normal liver, and the rate of binucleation as well as the proliferative activity of the binuclear cells was very low. The highest proliferative activity (BrdU labelling index) was found among the diploid tumour cells. The activity in mononuclear tetraploid and octoploid cells was reduced in inverse proportion to their increasing DNA content, possibly suggesting a loss of proliferative potential associated with polyploidization. There was a significant correlation between the proliferative activity of hepatocellular carcinoma cells and nonparenchymal liver cells in the different tumours, indicating that different cell types within a tumour may respond to common growth stimuli. Treatment of tumour-bearing rats with a promoting carcinogen (2-acetylaminofluorene) resulted in significant stimulation of tumour cell proliferation (all ploidy classes), whereas the proliferation of non-parenchymal (stromal) cells in the tumour was slightly inhibited. | lld:pubmed |
| pubmed-article:1330342 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1330342 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1330342 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1330342 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1330342 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1330342 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1330342 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1330342 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:1330342 | pubmed:issn | 0143-3334 | lld:pubmed |
| pubmed-article:1330342 | pubmed:author | pubmed-author:SeglenP OPO | lld:pubmed |
| pubmed-article:1330342 | pubmed:author | pubmed-author:StokkeTT | lld:pubmed |
| pubmed-article:1330342 | pubmed:author | pubmed-author:GrotmolTT | lld:pubmed |
| pubmed-article:1330342 | pubmed:author | pubmed-author:GerlyngPP | lld:pubmed |
| pubmed-article:1330342 | pubmed:author | pubmed-author:EriksteinBB | lld:pubmed |
| pubmed-article:1330342 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1330342 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:1330342 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1330342 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1330342 | pubmed:pagination | 1795-801 | lld:pubmed |
| pubmed-article:1330342 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:meshHeading | pubmed-meshheading:1330342-... | lld:pubmed |
| pubmed-article:1330342 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1330342 | pubmed:articleTitle | Reduced proliferative activity of polyploid cells in primary hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:1330342 | pubmed:affiliation | Department of Tissue Culture, Norwegian Radium Hospital, Montebello, Oslo. | lld:pubmed |
| pubmed-article:1330342 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1330342 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1330342 | lld:pubmed |
